1 |
Bellani G, Laffey JG, Pham T, et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries[J]. JAMA, 2016, 315 (8): 788-800.
|
2 |
姜琴,张文凯.脂多糖致急性肺损伤机制研究进展及还原型谷胱甘肽保护作用[J/CD].中华临床医师杂志(电子版),2017,11(4):645-649.
|
3 |
李建红,曹超,柴艳芬. TOLL样受体4与脓毒症免疫抑制相关性的研究进展[J/CD].中华危重症医学杂志(电子版),2015,8(4):213-216.
|
4 |
Tartey S, Takeuchi O. Pathogen recognition and Toll-like receptor targeted therapeutics in innate immune cells[J]. Int Rev Immunol, 2017, 36 (2): 57-73.
|
5 |
Feng G, Jiang ZY, Sun B, et al. Fisetin alleviates lipopolysaccharide-induced acute lung injury via TLR4-mediated NF-κB signaling pathway in rats[J]. Inflammation, 2016, 39 (1): 148-157.
|
6 |
Zhao H, Zheng Q, Hu X, et al. Betulin attenuates kidney injury in septic rats through inhibiting TLR4/NF-κB signaling pathway[J]. Life Sci, 2016 (144): 185-193.
|
7 |
李小冬,郭贝贝,杨英士,等.萝卜硫素抗癌机理研究进展[J].中药材,2015,38(8):1768-1771.
|
8 |
汤鲁明,王林霞,孙来芳,等.萝卜硫素对脓毒症急性肺损伤大鼠氧化损伤及脱嘌呤/脱嘧啶核酸内切酶1表达的影响[J/CD].中华危重症医学杂志(电子版),2017,10(4):246-251.
|
9 |
Umbrello M, Formenti P, Bolgiaghi L, et al. Current concepts of ARDS: a narrative review[J]. Int J Mol Sci, 2016, 18 (1). pii: E64.
|
10 |
Ruiz S, Vardon-Bounes F, Merlet-Dupuy V, et al. Sepsis modeling in mice: ligation length is a major severity factor in cecal ligation and puncture[J]. Intensive Care Med Exp, 2016, 4 (1): 22.
|
11 |
Sun Y, Yang T, Mao L, et al. Sulforaphane protects against brain diseases: roles of cytoprotective enzymes[J]. Austin J Cerebrovasc Dis Stroke, 2017, 4 (1). pii: 1054.
|
12 |
Qi T, Xu F, Yan X, et al. Sulforaphane exerts anti-inflammatory effects against lipopolysaccharide-induced acute lung injury in mice through the Nrf2/ARE pathway[J]. Int J Mol Med, 2016, 37 (1): 182-188.
|
13 |
Jiang X, Liu Y, Ma L, et al. Chemopreventive activity of sulforaphane[J]. Drug Des Devel Ther, 2018 (12): 2905-2913.
|
14 |
Yang M, Teng W, Qu Y, et al. Sulforaphene inhibits triple negative breast cancer through activating tumor suppressor Egr1[J]. Breast Cancer Res Treat, 2016, 158 (2): 277-286.
|
15 |
Fisher ML, Ciavattone N, Grun D, et al. Sulforaphane reduces YAP/ΔNp63α signaling to reduce cancer stem cell survival and tumorformation[J]. Oncotarget, 2017, 8 (43): 73407-73418.
|
16 |
Wu S, Zhou Y, Yang G, et al. Sulforaphane-cysteine induces apoptosis by sustained activation of ERK1/2 and caspase3 in human glioblastoma U373MG and U87MG cells[J]. Oncol Rep, 2017, 37 (5): 2829-2838.
|
17 |
Liu P, Atkinson SJ, Akbareian SE, et al. Sulforaphane exerts anti-angiogenesis effects against hepatocellular carcinoma through inhibition of STAT3/HIF-1α/VEGF signalling[J]. Sci Rep, 2017, 7 (1): 12651.
|
18 |
Lněnicková K, Dymáková A, Szotáková B, et al. Sulforaphane alters β-naphthoflavone-induced changes in activity and expression of drug-metabolizing enzymes in rat hepatocytes[J]. Molecules, 2017, 22 (11). pii: E1983.
|
19 |
Chen CT, Hsieh MJ, Hsieh YH, et al. Sulforaphane suppresses oral cancer cell migration by regulating cathepsin S expression[J]. Oncotarget, 2018, 9 (25): 17564-17575.
|
20 |
Taniguchi K, Karin M. NF-κB, inflammation, immunity and cancer: coming of age[J]. Nat Rev Immunol, 2018, 18 (5): 309-324.
|
21 |
何新华,陈云霞,李春盛.论重症感染[J].中华急诊医学杂志,2015,24(4):349-351.
|
22 |
Zong Y, Zhang H. Amentoflavone prevents sepsis-associated acute lung injury through Nrf2-GCLc-mediated upregulation of glutathione[J]. Acta Biochim Pol, 2017, 64 (1): 93-98.
|
23 |
Nallasamy P, Si H, Babu PV, et al. Sulforaphane reduces vascular inflammation in mice and prevents TNF-α-induced monocyte adhesion to primary endothelial cells through interfering with the NF-κB pathway[J]. J Nutr Biochem, 2014, 25 (8): 824-833.
|
24 |
Fonceca AM, Zosky GR, Bozanich EM, et al. Accumulation mode particles and LPS exposure induce TLR-4 dependent and independent inflammatory responses in the lung[J]. Respir Res, 2018, 19 (1): 15.
|
25 |
杜成成,尹婷,任如静,等.基于脂多糖-Toll样受体4信号通路抗内毒素血症机制研究进展[J].国际药学研究杂志,2017,44(12):1107-1112.
|
26 |
王凯,潘俊辉,王鹏.清肺理痰方对急性肺损伤大鼠肺组织NF-κB和Toll样受体4表达的影响[J].中国中医急症,2016,25(6):1001-1004.
|
27 |
He Z, Zhu Y, Jiang H. Inhibiting toll-like receptor 4 signaling ameliorates pulmonary fibrosis during acute lung injuryinduced by lipopolysaccharide: an experimental study[J]. Respir Res, 2009 (10): 126.
|